SYNDAX PHARMACEUTICALS INC (SNDX) Stock Balance Sheet
NASDAQ:SNDX - US87164F1057 - Common Stock
16.24 USD
+0.4 (+2.53%)
16 USD
-0.24 (-1.48%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 108.64M | 154.08M | 295.39M | 74.40M | 222.00M | |||
| Marketable Securities | 360.07M | 428.83M | 282.19M | 410.00M | 224.90M | |||
| Receivables | 37.42M | 13.87M | 1.23M | 4.10M | 400.00K | |||
| Inventories | 17.70M | 366.00K | N/A | N/A | N/A | |||
| Other Current Assets | 7.85M | 5.91M | 2.07M | 1.30M | 1.10M | |||
| Total Current Assets | 531.68M | 603.06M | 580.88M | 489.80M | 448.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.63M | 2.02M | 1.50M | 1.10M | 1.30M | |||
| Investments And Advances | 62.63M | 119.52M | 29.83M | 5.50M | N/A | |||
| Other Non-Current Assets | 217.00K | 217.00K | 680.00K | 900.00K | 0.00 | |||
| Total Non-Current Assets | 64.47M | 121.76M | 32.00M | 7.40M | 1.30M | |||
| TOTAL ASSETS | 596.15M | 724.82M | 612.88M | 497.20M | 449.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 19.44M | 12.13M | 12.00K | 0.00 | 0.00 | |||
| Accrued Expenses | 66.21M | 59.41M | 40.89M | 24.70M | 14.80M | |||
| Accounts Payable | 17.35M | 11.63M | 9.96M | 4.40M | 5.70M | |||
| Other Current Liabilities | 9.99M | 20.39M | 7.23M | 0.00 | 200.00K | |||
| Total Current Liabilities | 112.99M | 103.55M | 58.10M | 29.10M | 20.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 325.74M | 331.56M | 10.00K | 0.00 | 19.90M | |||
| Other Non-Current Liabilities | N/A | 1.58M | 578.00K | 700.00K | 700.00K | |||
| Total Non-Current Liabilities | 325.74M | 333.14M | 588.00K | 700.00K | 20.60M | |||
| TOTAL LIABILITIES | 438.73M | 436.69M | 58.68M | 29.80M | 41.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.38B | -1.22B | -902.40M | -693.00M | -543.70M | |||
| Additional Paid In Capital | 1.53B | 1.51B | 1.46B | 1.16B | 952.00M | |||
| Common Shares | 9.00K | 9.00K | 8.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 285.00K | 163.00K | 218.00K | -800.00K | 0.00 | |||
| Shares Outstanding | 86.06M | 85.69M | 84.83M | 68.10M | 55.00M | |||
| Tangible Book Value per Share | 1.83 | 3.36 | 6.53 | 6.86 | 7.43 | |||
| Total Shareholders' Equity | 157.42M | 288.12M | 554.20M | 467.40M | 408.40M | |||
| TOTAL LIABILITIES AND EQUITY | 596.15M | 724.82M | 612.88M | 497.20M | 449.70M | |||
| Statistics | ||||||||
| Debt/Equity | 2.07 | 1.15 | 0.00 | N/A | 0.05 | |||
| Current Ratio | 4.71 | 5.82 | 10.00 | 16.83 | 21.66 | |||
| Return On Assets (ROA) | -56.19% | -43.98% | -34.16% | -30.03% | 5.54% | |||
| Return On Equity (ROE) | -212.79% | -110.63% | -37.78% | -31.94% | 6.10% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 4.82% | |||
All data in USD , ROIC based on taxRate of 0.21